JAMA Oncology · 2021 · 13 citations · 1 references
Public AffairsOncologyPharmacoeconomicsHealth InsuranceManaged CareOncology PharmacotherapyHealth Care CostsHealthcare Cost AnalysisHealthcare PricingOut-of-pocket SpendingPharmaceutical EconomicsPhysician EconomicsCancer Cost BurdenCoverage Of Brand-name DrugsDrug Cost AnalysisDrug Cost ReimbursementInpatient Out-of-pocket CostsOut-of-pocket Drug SpendingOut-of-pocket Prescription CostsPrescription Drug Costs
This cross-sectional study examines patients’ out-of-pocket costs with and without rebate pass-through to point-of-sale prices for cancer drugs under Medicare Part D.
1